Inaugural CEO Roundtable on Cancer

防癌抗癌总裁圆桌会中国项目成立大会
Partnership, Progress & Hope
合作
进步
展望
Peninsula Hotel | Shanghai, China·October 10, 2013
Summary Report
Inaugural CEO Roundtable on Cancer-China
October 10, 2013
Peninsula-Shanghai
Partnership, Progress and Hope
Page 1
Page 2
Executive Summary
Inaugural CEO Roundtable on Cancer-China
Facts Sheet


Convened on Thursday, October 10, 2013 from 1:30pm to 7:30pm at Peninsula Hotel,
Shanghai.
Total participants: 40, including:
 25 member participants: 7 CEOs, 11 executive level representatives, from 17
companies representing 6 different industries
 15 honored guests (5 government, 5 NGO, 4 academic, 1 media)
Participant Chart
1
5
Member Candidate
Government
4
Academic
5
25
NGO
Media
 Company list: Allergan, Amgen, Baxter, Bayer, BMS, Boehringer Ingelheim, GE,
GM, IMS Consulting, J&J, Novartis, Publicis, Quintiles, Roche, Roland Berger
Consulting, Sanofi and SAS Institute.
Page 3
 Government support: The Honorable Professor Jianguang XU, Director
General of Shanghai Municipal Commission of Health and Family Planning,
attended the CEO Roundtable-Chikna as a representative of Shanghai municipal
government. Director General XU, a physician expert in hand surgery, formerly
served as the head of the Shanghai Food and Drug Administration. The Shanghai
Municipal Commission of Health and Family Planning is the highest level
department in Shanghai municipal government, responsible for all health-related
affairs, including public health issues, disease control, hospital and medical staff
management, family planning for all of Shanghai covering 2,448 square miles
with 14.3 million residents. The Shanghai municipality is one of the four
municipalities that are under direct supervision of China’s central government.

Page 4
Keynote speakers: Tom Pike, CEO of Quintiles; Dr. Jean WU, Medical Director of GE
Greater China; Dr. Jean-Luc Lowinski, President of Sanofi China and two
representatives from Global CEO Cancer Gold Standard accredited companies: J&J
(Ruiyan LI) and Novartis (Sara HOU). They addressed the importance of Workplace
Wellness and how the CEO Roundtable on Cancer with its flagship product, the CEO
Cancer Gold Standard, has supported their health-devoted programs. In addition, they
shared reasons why the CEO Cancer Gold Standard ought to be embraced by employers
across China.
Honored Guests:
Prof. Shukui QIN (秦叔逵)
 Co-chairman, inaugural CEO Roundtable on Cancer-China
 Chairman, CSCO Foundation
 Immediate Past President, CSCO
 Vice President of Medical Education, CSCO
Hon. Prof. Jianguang XU (徐建光)
 Director General and Deputy Communist Party Secretary, Shanghai Municipal
Commission of Population and Family Planning
 Director General and Deputy Communist Party Secretary, Shanghai Food and
Drug Administration
Prof. Meilin LIAO (廖美琳), MD
 Co-founder of Chinese Society of Clinical Oncology (CSCO)
 Chief, Shanghai Lung Cancer Medical Center
nd
 Professor, Shanghai 2 Medical University Shanghai Chest Hospital
Prof. Jin LI (李进), MD
 Secretary General of CSCO
 Dean, Department of Medical Oncology, Fudan University Shanghai
Cancer Center
 Director, Cancer Biotherapy Research Center
Prof. Shun LU (陆舜), MD, PhD
 Deputy General Secretary of CSCO
 Vice director of Chinese Society of Lung Cancer
 Vice director of Shanghai Society of Cancer
 Chief, Shanghai Lung Cancer Center
Prof. Lunxiu QIN (钦伦秀), MD, PhD
 Representative of Hon. Jian SONG
 Professor of Liver Surgery, Vice-director of Liver Cancer Institute,
Fudan University
 Founding members of the International Liver Cancer Association
Page 5
Chairman’s Remarks:
The CEO Roundtable on Cancer Chairman, Chris Viehbacher, opened the inaugural CEO
Roundtable on Cancer-China at 2:10 p.m. on October 10, 2013. In his opening remarks, he
briefly introduced the participants to the history of the CEO Roundtable on Cancer, and, in
particular, cited President George H.W. Bush’s leadership and original challenge to be bold and
venturesome.
Chairman Viehbacher noted that 60% of cancer deaths
can be prevented, and, therefore, it is essential and
highly effective to focus on cancer prevention. The
CEO Roundtable on Cancer, with its powerful
initiatives, is dedicated to preventing cancer and
prolonging lives. Virtually in every country throughout
the world, cancer is a serious public health issue. The
CEO Roundtable on Cancer’s model for risk reduction,
early detection and quality care has great implications
for improved health. Chairman Viehbacher mentioned
that during his attendance of the Asia Pacific Economic
Cooperation (APEC) conference in Bali, Indonesia, the
Health Minister of Indonesia expressed her interest in
the CEO Roundtable on Cancer. Indonesia has the
highest smoking rate in the world and this is reflected in
tobacco-related morbidity and mortality. The CEO
Roundtable-China was fostered when he and Dr. Martin
Murphy visited Dr. CHEN Zhu, China’s then Minister
of Health. Minister Chen had just initiated a Smoke-free
Workplace initiative in September 2012. The cost of healthcare in China has been escalating.
Chairman Viehbacher then briefly introduced the CEO Cancer Gold StandardTM with its Five
Pillars. He stressed that it is very important for employers to demonstrate how much their
employees mean to them by investing in their health. The Gold Standard, with its focus on
prevention, clearly demonstrates the importance of each employee to the success of an
organization. The CEO Roundtable is introducing an effective way for every healthcare system
around the world to address cancer. It is not an easy task. Chairman Viehbacher cited some
examples of Sanofi’s anti-smoking challenges. He mentioned that even encouraging employees
to use stairs might not be easy to accomplish because it raises unexpected concerns from other
authorities. The conclusion is that to be successful, leaders themselves must be fully involved
and committed.
Chairman Viehbacher then spoke of the achievements of Gold Standard in the U.S. and
expressed his admiration for all distinguished Gold Standard accredited employers. He then
recognized an exemplary employer — Johnson & Johnson, and its marvelous achievements after
its Gold Standard accreditation.
Page 6
Before closing, Chairman Viehbacher spoke briefly about the CEO Roundtable’s Life Sciences
Consortium and Project Data Sphere, a new initiative designed to accelerate cancer research. He
acknowledged Dr. Jim Goodnight and SAS’s leadership and contribution to these important
projects that are well underway. He mentioned that CEO Roundtable-China employers will have
the opportunity to engage in these two initiatives in China.
Chairman Viehbacher closed his speech by saluting President Bush’s continuous and enthusiastic
support of the CEO Roundtable. He concluded by saying, “cancer is a devastating disease …
let’s all work to make a difference”.
Chris Viehbacher with Dr. Martin J. Murphy, Jr.
October 10, 2013; The Peninsula-Shanghai
Page 7
Co-Chairman’s Remarks:
Professor Shukui QIN, Chairman of Chinese Society of Clinical Oncology (CSCO) Foundation
and Co-Chairman of the inaugural CEO Roundtable on Cancer-China, welcomed all the
participants to the inaugural CEO Roundtable. He acknowledged the CEO Roundtable on
Cancer and its Gold Standard initiative, praising it as a great platform for leaders from all
sectors of society to come together to share and learn from each other.
Prof. QIN then gave a brief introduction to CSCO. For the past 16 years, CSCO has made great
progress in China and it looks forward to a long-term collaboration with the CEO Roundtable on
Cancer-China to help conquer cancer as partners.
Prof. QIN recognized Dr. Martin Murphy’s special contribution in this regard in China and
expressed his appreciation to Dr. Murphy’s support for the development of CSCO.
Lastly, Prof. QIN pointed out that China is still a developing country with a growing number of
cancer patients. He called for cooperation from all sectors of society to join this collective battle
against cancer.
Prof. Shukui QIN, Co-Chairman of the inaugural CEO Roundtable on Cancer-Ch
Page 8
Business Report:
Dr. Martin Murphy, CEO of the CEO Roundtable on Cancer opened his report by calling
everyone’s attention to the letter from President George H.W. Bush from which he read the
following excerpt:
Dr. Murphy saluted Dr. CHEN Zhu, China’s former Minister of Health, and his suggestion to
combine the strength of the CEO Roundtable on Cancer with the ongoing Healthy Cities
initiative in China. Dr. Murphy then recognized the following honored guests in order:







Prof. Shukui QIN
Director General Prof. Jianguang XU
Prof. Zhixing CHEN
Prof. Meilin LIAO
Prof. Jin LI
Prof. Shun LU
Prof. Jian SONG (represented by Prof. Lunxiu QIN)
Dr. Murphy then acknowledged Novartis and Johnson & Johnson for their distinctive
achievements in becoming accredited as the first global CEO Cancer Gold Standard employers,
and briefly mentioned a significant peer-reviewed paper on Johnson & Johnson’s experience
with the Gold Standard, published recently in the peer-reviewed journal Population Health
Management.
The following companies were then recognized for their Pioneer Partnership with CEO
Roundtable on Cancer-China:



Sanofi China
GSK China
Boehringer-Ingelheim China
Dr. Murphy called on all participants to make a pledge to be bold and venturesome to create and
foster the newly-established CEO Roundtable in China.
Page 9
Lastly, Dr. Murphy recognized Ray Wang, founding Senior Director of CEO Roundtable on
Cancer-China.
Dr. Martin Murphy calls on the participants to be bold and venturesome
by joining the CEO Roundtable on Cancer-China
Page 10
Path Forward:
Member Pledges have been sent to participating companies. Each participating company is
expected to designate an appropriate corporate representative(s) to form the CEO Cancer Gold
Standard Task Force-China in order to do something bold and venturesome about cancer within
their own corporate families. The Task Force will be formed by the close of December 2013, and
the first Task Force meeting will be convened during January 2014. The Task Force will decide
how to blend the U.S. Gold Standard respectful of Chinese culture whilst retaining the essence
of the Global Gold Standard.

Timetable
o Mid-October to late November 2013
Task Force candidate recruitment
o December 2013
Discussions on CEO Cancer Gold Standard-China. Debate and review
o January 2014
First Task Force meeting
o After the meeting
First version of CEO Cancer Gold Standard-China ready for CEO and
Chairman’s review
Signature Wall
Inaugural CEO Roundtable on Cancer-China
Page 11
Inaugural CEO Roundtable on Cancer – China
Class Photo
1. Jing XIA
2. Ray Wang
3. James LI
4. Cliff WU
5. Mary THORNTON
6. Meilin LIAO
7. Shukui QIN
8. Chris VIEHBACHER
9. Victoria ELEGANT
10. Craig Narveson
11. Jeffrey YU
12. Tom PIKE
13. Johannes DIETSCH
Page 12
14. Ken JARRETT
15. Lauren VIEHBACHER
16. Fabrice BASCHIERA
17. Martin MURPHY
18. Jean-Luc LOWINSKI
19. Yong ZENG
20. Jin LI
21. David KHOUGAZIAN
22. Jeffrey QUE
23. James CAI
24. Ruiyan LI
25. William LIANG
26. Jean WU
27. Helen YAN
28. Shirley ZHAO
29. Shun LU
30. Susan HINE
31. Ioana KRAFT
32. Lunxiu QIN
33. Xiaoning ZOU
34. Bruce LIU
防癌抗癌总裁圆桌会中国项目成立大会
Partnership, Progress & Hope
合作
进步
展望
Member Attendee List
. Peninsula Hotel | Shanghai, China·October 10, 2013
Ruiyan LI
Wellness Manager
Allergan, China
Shirley ZHAO
President
Amgen, China
James LI
General Manager
Baxter Healthcare, Asia-Pacific Area
Victoria ELEGANT
Vice-President, Medical, Regulatory and Clinical
Affairs
Bayer, Greater China
Johannes DIETSCH
President
Bristol-Myers Squibb, China
William LIANG
Vice President, Oncology Business Unit
CEO Roundtable on Cancer
Martin MURPHY
Chief Executive Officer
Ray WANG
Senior Director, China
Novartis, China
Sara HOU
General Manager, OBU
Publicis, Greater China
Jeffrey YU
Chief Executive Officer
Craig NARVESON
Business Development Director, APAC
Publicis Healthcare Communications Group
Quintiles
Tom PIKE
Chief Executive Officer
Roche, Asia Pacific
James CAI
Head, Oncology Clinical Development
Roland Berger, China
Bruce LIU
Partner
Sanofi
General Electric, Greater China & Korea
Jean WU
Medical Director
Yong ZENG
General Manager, Precision Diagnostics, General
Electric Healthcare
General Motors, China
Mary THORNTON
Human Resource Director
IMS Consulting Group
Lauren VIEHBACHER
Senior Consultant
Johnson & Johnson, China
Jeffrey QUE
Vice President Government Affairs & Policy
Chris VIEHBACHER
Chief Executive Officer
David KHOUGAZIAN
Chief of Staff
Jean-Luc LOWINSKI
President, Greater China
Fabrice BASCHIERA
General Manager, Commercial operations
Frank JIANG
Vice President, Global R&D
Helen YAN
Head of Communications, China & Asia
SAS, Greater China
Cliff WU
President
Page 13
防癌抗癌总裁圆桌会中国项目成立大会
Partnership, Progress & Hope
合作
进步
展望
Honored Guest List
Peninsula Hotel | Shanghai, China·October 10, 2013
American Chamber of Commerce in Shanghai
Ken JARRETT
President
China Daily
Hongyi WANG
Journalist
Chinese Society of Clinical Oncology (CSCO)
Prof. Shukui QIN
Chairman, CSCO Foundation
Prof. Meilin LIAO
Co-founder
Prof. Jin LI
Secretary General
Prof. Shun LU
Deputy Secretary General
European Union Chamber of Commerce in China
Ioana KRAFT
General Manager
National Health and Family Planning
Commission
Jing XIA
Staff
Representative of Hon. Jian SONG
Prof. Lunxiu QIN,
Vice-director of Liver Cancer Institute,
Fudan University
Shanghai Foreign Affairs Office
Yiling QIAN
Staff
Page 14
Shanghai Medicine and Health Development
Foundation
Prof. Zhixing CHEN
Vice President
Prof. Xiaoning ZOU
Chief, Department of International
Cooperation
Shanghai Municipal Commission of Health and
Family Planning
Hon. Jianguang XU
Director General
Huihong QIAO
Director
U.S. Consulate General Shanghai
Susan HINE
Consular Representative
For additional information, please contact one of the following
individuals or visit our Web sites:
www.CEORoundtableOnCancer.org
www.CancerGoldStandard.org
Dr. Martin J. Murphy, Jr.
Chief Executive Officer
3920 Dover Road
Durham, North Carolina 27707-5157
Office: +919-402-8750
Mobile: +919-641-5304
E: [email protected]
Ray Wang
Senior Director
500 Zhidan Road
Shanghai, China
Mobile: +86-1851-618-0159
E: [email protected]
Page 15